Skip to main content
Erschienen in: Archives of Dermatological Research 3/2007

01.06.2007 | Original Paper

Lack of association between NPHS2 gene polymorphisms and Henoch-Schönlein purpura nephritis

verfasst von: Yang Zhang, Xu Xudong, Lizhong Du, Weizhong Gu, Yuwen Dai, Aimin Liu, Yonghui Xia, Jianhua Mao

Erschienen in: Archives of Dermatological Research | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Henoch-Schönlein purpura (HSP) is one of the most common forms of small-vessel vasculitis in childhood, and renal involvement (HSP nephritis, HSPN) is the main determinant of morbidity after acute phase. Considering the racial diversity and clinical heterogeneity in the prevalence, genetic factors might play a role in pathogenesis of HSP and HSPN. Direct sequencing was performed after PCR amplification of all 8 exons of the NPHS2 gene in 20 Chinese children with HSPN and 30 controls in present study. The genetic analyses revealed 3 polymorphisms (954T > C heterozygous, 1038A > G heterozygous and homozygous, all in exon 8) in 7 out of 20 patients studied, but there was no significant difference in the genotypic and allelic frequencies of these polymorphisms between the patients and controls. The result did not support the possible role of the NPHS2 gene in susceptibility to HSPN in the population studied. Studies in a larger sample population with different genetic backgrounds will be necessary in the future.
Literatur
1.
Zurück zum Zitat Amoli MM, Calvino MC, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2004) Interleukin 1 beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 31:295–298PubMed Amoli MM, Calvino MC, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2004) Interleukin 1 beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 31:295–298PubMed
2.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 29:1404–1407PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 29:1404–1407PubMed
3.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed
4.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 29:948–949PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 29:948–949PubMed
5.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations. J Rheumatol 29:945–947PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations. J Rheumatol 29:945–947PubMed
6.
Zurück zum Zitat Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2001) HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed Amoli MM, Thomson W, Hajeer AH, Calvino MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2001) HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol 28:1266–1270PubMed
7.
Zurück zum Zitat Amoli MM, Mattey DL, Calvino MC, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE, Gonzalez-Gay MA (2001) Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J Rheumatol 28:1014–1018PubMed Amoli MM, Mattey DL, Calvino MC, Garcia-Porrua C, Thomson W, Hajeer AH, Ollier WE, Gonzalez-Gay MA (2001) Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J Rheumatol 28:1014–1018PubMed
8.
Zurück zum Zitat Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354PubMedCrossRef Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354PubMedCrossRef
9.
Zurück zum Zitat Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM (2001) Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12:2742–2746PubMed Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM (2001) Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12:2742–2746PubMed
10.
Zurück zum Zitat Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003PubMedCrossRef Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003PubMedCrossRef
11.
Zurück zum Zitat Davin JC, Weening JJ (2003) Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy? Pediatr Nephrol 18:1201–1203PubMedCrossRef Davin JC, Weening JJ (2003) Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy? Pediatr Nephrol 18:1201–1203PubMedCrossRef
12.
Zurück zum Zitat Di Duca M, Oleggini R, Sanna-Cherchi S, Pasquali L, Di Donato A, Parodi S, Bertelli R, Caridi G, Frasca G, Cerullo G, Amoroso A, Schena FP, Scolari F, Ghiggeri GM (2006) Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases. Kidney Int 70:1332–1341PubMedCrossRef Di Duca M, Oleggini R, Sanna-Cherchi S, Pasquali L, Di Donato A, Parodi S, Bertelli R, Caridi G, Frasca G, Cerullo G, Amoroso A, Schena FP, Scolari F, Ghiggeri GM (2006) Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases. Kidney Int 70:1332–1341PubMedCrossRef
13.
Zurück zum Zitat Dusel JA, Burdon KP, Hicks PJ, Hawkins GA, Bowden DW, Freedman BI (2005) Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 68:256–262PubMedCrossRef Dusel JA, Burdon KP, Hicks PJ, Hawkins GA, Bowden DW, Freedman BI (2005) Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 68:256–262PubMedCrossRef
14.
Zurück zum Zitat Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8:63–75PubMedCrossRef Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8:63–75PubMedCrossRef
16.
Zurück zum Zitat Guan N, Ding J, Zhang J, Yang J (2003) Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol 18:1122–1127PubMedCrossRef Guan N, Ding J, Zhang J, Yang J (2003) Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol 18:1122–1127PubMedCrossRef
17.
Zurück zum Zitat Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S (2003) In situ evaluation of podocin in normal and glomerular diseases. Kidney Int 64:2092–2099PubMedCrossRef Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S (2003) In situ evaluation of podocin in normal and glomerular diseases. Kidney Int 64:2092–2099PubMedCrossRef
18.
Zurück zum Zitat Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:388–393PubMed Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:388–393PubMed
19.
Zurück zum Zitat Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA (2003) Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14:2063–2071PubMedCrossRef Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA (2003) Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14:2063–2071PubMedCrossRef
20.
Zurück zum Zitat Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L (2006) Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 21:1666–1675PubMedCrossRef Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L (2006) Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 21:1666–1675PubMedCrossRef
21.
Zurück zum Zitat Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calvino MC, Ollier WE, Gonzalez-Gay MA (2005) Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 32:1081–1085PubMed Martin J, Paco L, Ruiz MP, Lopez-Nevot MA, Garcia-Porrua C, Amoli MM, Calvino MC, Ollier WE, Gonzalez-Gay MA (2005) Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. J Rheumatol 32:1081–1085PubMed
22.
Zurück zum Zitat Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology criteria for the classification of Henoch-Schönlein purpura Arthritis Rheum 33:1114–1121PubMedCrossRef Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology criteria for the classification of Henoch-Schönlein purpura Arthritis Rheum 33:1114–1121PubMedCrossRef
23.
Zurück zum Zitat Motoyama O, Iitaka K (2005) Familial cases of Henoch-Schonlein purpura in eight families. Pediatr Int 47:612–615PubMedCrossRef Motoyama O, Iitaka K (2005) Familial cases of Henoch-Schonlein purpura in eight families. Pediatr Int 47:612–615PubMedCrossRef
24.
Zurück zum Zitat Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F (2006) Henoch-Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 99:253–265PubMedCrossRef Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F (2006) Henoch-Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 99:253–265PubMedCrossRef
25.
Zurück zum Zitat Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, Li PK, Lai FM (2005) Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 361:182–190PubMedCrossRef Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, Li PK, Lai FM (2005) Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 361:182–190PubMedCrossRef
26.
Zurück zum Zitat Winn MP (2002) Not all in the family: mutations of podocin in sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:577–579PubMed Winn MP (2002) Not all in the family: mutations of podocin in sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:577–579PubMed
27.
Zurück zum Zitat Yi ZW, Fang XL, Wu XC, He XJ, He QN, Dang XQ, Zhu CP, Mo SH (2006) Role of PAX2 gene polymorphisms in Henoch-Schönlein purpura nephritis. Nephrology (Carlton) 11:42–48CrossRef Yi ZW, Fang XL, Wu XC, He XJ, He QN, Dang XQ, Zhu CP, Mo SH (2006) Role of PAX2 gene polymorphisms in Henoch-Schönlein purpura nephritis. Nephrology (Carlton) 11:42–48CrossRef
Metadaten
Titel
Lack of association between NPHS2 gene polymorphisms and Henoch-Schönlein purpura nephritis
verfasst von
Yang Zhang
Xu Xudong
Lizhong Du
Weizhong Gu
Yuwen Dai
Aimin Liu
Yonghui Xia
Jianhua Mao
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 3/2007
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-007-0752-y

Weitere Artikel der Ausgabe 3/2007

Archives of Dermatological Research 3/2007 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.